C

Alcon Inc. ALC

$65.18 -$1.12-1.69% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Alcon Inc. is a global eye care company focused on surgical and vision care products for ophthalmologists, optometrists, hospitals, ambulatory surgery centers, and consumers. The company operates primarily in the medical technology and healthcare sectors, with activities spanning ophthalmic surgical equipment, implantable products, contact lenses, and ocular health solutions. Alcon generates revenue through the sale of cataract surgery systems, intraocular lenses, vitreoretinal surgical products, daily disposable and reusable contact lenses, and over-the-counter eye care products. Its business is generally divided into two major operating segments: Surgical and Vision Care.

Alcon traces its origins to 1945 in Texas as a small pharmacy focused on eye care products. The company expanded internationally over several decades and was acquired by Nestlé in 1977 before becoming part of Novartis through a series of transactions completed in the 2000s. In 2019, Alcon was spun off from Novartis and began operating as an independent publicly traded company listed on the SIX Swiss Exchange and the New York Stock Exchange under the ticker ALC. The company has positioned itself as one of the largest dedicated eye care companies globally, benefiting from broad ophthalmic product breadth, established surgeon relationships, and recurring demand driven by aging populations and vision correction trends.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Monday, August 10, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
41 589 112 110
Address
Chemin de Blandonnet 8
Vernier
Geneva, 1214
Country
Year Founded

Headlines

9/3/2026 - Seeking Alpha - Long Ideas
9/3/2026 - Seeking Alpha - Healthcare
8/26/2026 - SeekingAlpha.com: All News
8/19/2026 - Insider Monkey
8/17/2026 - Nasdaq News: Markets